At a glance
The July 20, 2020, Clinical Laboratory Covid-19 Response (CLCR) call included updates on autopsies and public health importance for COVID-19, COVID-19 samples packaging and shipping issues, as well as an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems
Autopsies and Public Health Importance for COVID-19: Roose Martines, CDC Division of High-Consequence Pathogens and Pathology (DHCPP) Sarah Reagan-Steiner, CDC Division of High-Consequence Pathogens and Pathology (DHCPP)
COVID-19 Samples: Packaging and Shipping Issues: Stuart Streck, U.S. Department of Transportation
FDA Update: Tim Stenzel and Sara Brenner, Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.